Filing Details
- Accession Number:
- 0001209191-17-014720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-27 16:13:42
- Reporting Period:
- 2017-02-24
- Filing Date:
- 2017-02-27
- Accepted Time:
- 2017-02-27 16:13:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108109 | Community Health Systems Inc | CYH | Services-General Medical & Surgical Hospitals, Nec (8062) | 133893191 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190774 | Jr Mitchell H Watson | 4000 Meridian Boulevard Franklin TN 37067 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-24 | 1,732 | $9.24 | 4,777 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | $0.00 | 2015-03-01 | 2024-02-29 | 1,474 | 1,474 | Direct |
Common Stock | Restricted Stock Units | $0.00 | 2016-03-01 | 2025-02-28 | 2,859 | 2,859 | Direct |
Common Stock | Restricted Stock Units | $0.00 | 2017-03-01 | 2026-02-28 | 13,484 | 13,484 | Direct |
Common Stock | Stock Units (SU) | $0.00 | 15,072 | 15,072 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2024-02-29 | 1,474 | 1,474 | Direct |
2025-02-28 | 2,859 | 2,859 | Direct |
2026-02-28 | 13,484 | 13,484 | Direct |
15,072 | 15,072 | Direct |
Footnotes
- These shares were sold in a series of transactions at an average sales price of $9.236 per share.
- The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock upon cessation as a director or upon a date specified by the director.